chrX-18507092-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_001323289.2(CDKL5):c.-5T>A variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0000922 in 1,182,821 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.000084 ( 0 hom. 19 hem. )
Consequence
CDKL5
NM_001323289.2 5_prime_UTR
NM_001323289.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.73
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BP6
Variant X-18507092-T-A is Benign according to our data. Variant chrX-18507092-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 379694.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00017 (19/111623) while in subpopulation EAS AF= 0.00505 (18/3561). AF 95% confidence interval is 0.00327. There are 0 homozygotes in gnomad4. There are 6 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.-5T>A | 5_prime_UTR_variant | 2/18 | ENST00000623535.2 | ||
CDKL5 | NM_001037343.2 | c.-5T>A | 5_prime_UTR_variant | 3/22 | |||
CDKL5 | NM_003159.3 | c.-5T>A | 5_prime_UTR_variant | 2/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.-5T>A | 5_prime_UTR_variant | 2/18 | 1 | NM_001323289.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000170 AC: 19AN: 111571Hom.: 0 Cov.: 23 AF XY: 0.000178 AC XY: 6AN XY: 33743
GnomAD3 genomes
AF:
AC:
19
AN:
111571
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
33743
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000382 AC: 70AN: 183202Hom.: 0 AF XY: 0.000340 AC XY: 23AN XY: 67660
GnomAD3 exomes
AF:
AC:
70
AN:
183202
Hom.:
AF XY:
AC XY:
23
AN XY:
67660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000840 AC: 90AN: 1071198Hom.: 0 Cov.: 25 AF XY: 0.0000558 AC XY: 19AN XY: 340290
GnomAD4 exome
AF:
AC:
90
AN:
1071198
Hom.:
Cov.:
25
AF XY:
AC XY:
19
AN XY:
340290
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000170 AC: 19AN: 111623Hom.: 0 Cov.: 23 AF XY: 0.000177 AC XY: 6AN XY: 33805
GnomAD4 genome
AF:
AC:
19
AN:
111623
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
33805
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 28, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at